Navigation Links
Nanotechnologies in Bioscience, Live Webinar on May 10
Date:4/24/2013

Toronto, Canada (PRWEB) April 24, 2013

Join the presenters for a live presentation that will include a case study of a company using nanotechnology in targeted therapeutics and drug development.

Dr. Toby Gill, industry expert on nanotechnology, will provide an overview of the current developments taking place around the applications of nanotechnologies in the field of Biosciences. This general introduction is aimed at those interested in learning more about the emerging applications of nanotechnologies in biosciences.

Dr. Jeff Hrkach, Senior Vice President of Technology, Research and Development at BIND Therapeutics, will then present a case study that includes different approaches to targeted therapeutics such as molecularly targeted drug molecules, nano medicines and antibody-drug conjugates.

A live Q&A with the audience will follow the main presentation. For more information or to register for this event, please go to http://xtks.in/xto596p.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year, thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Zayeeta Dasgupta, M.Sc in Life Science and Business Management
1-(416) 977-6555 ext. 260

Read the full story at http://www.prweb.com/releases/2013/4/prweb10652914.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Nanotechnologies and bio-inspiration for healthcare, communication, more will highlight SPIE Microtechnologies
2. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
3. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
4. Going a step Further: Phase IV and Post-Marketing Observational Studies add Value to new Therapies, life Science Webinar Hosted by Xtalks
5. New Webinar on Sensor-based Logistics for Life Science Supply Chains, Hosted by Xtalks
6. Risk-based Approach to Monitoring: Deployment Insights and Lessons Learned, New Xtalks Webinar
7. Risk Assessment and Mitigation in Phase I Trials in High Risk Compounds: A Continuously Developing Process, new life science webinar hosted by Xtalks
8. Evolving Market Access in the APAC Region, a New Xtalks Life Sciences Webinar
9. Positive Psychology Webinar for Coaches and Career Counselors Led by Accentuate Consulting
10. Site Quality Management to Optimize Risk-Based and Centralized Monitoring, New Life Science Webinar Hosted by Xtalks
11. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):